American Association for Cancer Research
Browse
crc-22-0489-s06.docx (64 kB)

Supplementary Figure S1 from Development and Validation of a 15-gene Expression Signature with Superior Prognostic Ability in Stage II Colorectal Cancer

Download (64 kB)
journal contribution
posted on 2023-08-30, 14:20 authored by Matjaz Rokavec, Elif Özcan, Jens Neumann, Heiko Hermeking

Supplementary Figure S1 shows pathway analysis and clinico-pathological associations of unfavorable prognostic genes.

Funding

Deutschen Konsortium für Translationale Krebsforschung (DKTK)

History

ARTICLE ABSTRACT

We identified and validated a 15-gene expression signature for robust prognostication and stratification of patients with stage II colorectal cancer, with superior performance when compared with currently used biomarkers. Therefore, the 15-gene expression signature has the potential to improve the prognostication and treatment decisions for patients with stage II colorectal cancer.

Usage metrics

    Cancer Research Communications

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC